Clinical Trial: Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Compassionate Use of the CliniMACS® CD34 Reagent System for Patients Requiring a Post Hematopoietic Stem Cell Transplant Boost of Donor Hematopoietic Stem Cells

Brief Summary: This clinical trial studies how well donor stem cell boost works in treating patients with low blood cells after donor stem cell transplant. Donor stem cell boost may increase low blood cell counts caused by hematologic cancer or its treatment.